Pranob Bhattacharya discusses zolbetuximab, a first-in-class investigational therapy for the treatment of gastric cancer. Daily vitamin D3 supplementation was associated with reduced risk of relapse or death in digestive tract cancer. A study evaluated the predictive ability of the combined SMI and PNI to assess survival in advanced gastric cancer patients. A study found that adding docetaxel to S-1 as postoperative chemotherapy improves survival in gastric cancer patients. Rutika Mehta, MD, assistant professor of oncology at the Moffitt Cancer Center, discusses treatment options for upper ... Eradication therapy for chronic Helicobacter pylori (H. pylori) infection reduces the risk for gastric cancer (GC), ... $4.7 Million NIH Grant Supports Stem Cell Cloning
... According to an article in BMC Cancer, the most accurate inflammation and nutritional biomarkers for predicting the ... Incidence of gastric cancer has increased in people aged ≤40 years since 1980 in some countries, according to a new ... On April 16, the U.S. Food and Drug Administration (FDA) approved nivolumab in combination with fluoropyrimidine- and ... A breath analyzer may be able to identify gastric cancer, a study discovered.
... A new biomarker discovered by researchers at the University of Arizona Health Science may help with early detection of ... Researchers recently reported the results of the randomized, controlled phase 3 KEYNOTE-062 trial, which compared ... According to the findings of the Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group CLASS02 study, which ... Surgical delays due to SARS-CoV-2 (COVID-19) are linked with shorter survival times in colorectal cancer, according to a ... Patients with Helicobacter pylori (H. pylori) infection and a first-degree family history of gastric cancer had a ... The U.S. Food and Drug Administration approved Ayvakit™ (avapritinib) for adults with unresectable or metastatic ... The findings of a new Mayo Clinic study published in the journal Surgery suggest that many stomach cancer patients under ... A new study highlighted the outcomes of an artificial intelligence (AI) system in detecting upper gastrointestinal ... Topline results from the pivotal phase III INVICTUS trial showed that the novel drug ripretinib improved ...